Mass output and particle size distribution of glucocorticosteroids emitted from different inhalation devices depending on various inspiratory parameters.

@article{Kamin2002MassOA,
  title={Mass output and particle size distribution of glucocorticosteroids emitted from different inhalation devices depending on various inspiratory parameters.},
  author={Wolfgang Kamin and Tilman Genz and Sascha Roeder and Gerhard Scheuch and Thomas Trammer and Ralf Juenemann and Rolf Michael Cloes},
  journal={Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine},
  year={2002},
  volume={15 1},
  pages={
          65-73
        }
}
  • W. Kamin, T. Genz, +4 authors R. Cloes
  • Published 2002
  • Chemistry, Medicine
  • Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine
Efficient inhalation therapy depends on successful delivery of the drug to the lung. The efficacy of drug delivery is not only influenced by the characteristics of the inhalation device, but also by the patient's handling of the device and by the inspiratory maneuver achieved through the device. We analyzed the output characteristics of three different chlorofluorocarbon (CFC)-free breath-actuated inhalers for inhaled glucocorticosteroids (BUD Turbohaler, FP Diskus/Accuhaler and HFA-BDP… Expand
Effect of Inhalation Manoeuvre Parameters In-Vitro and Ex-Vivo on the Dose Emission and the Aerodynamic Characteristics of Formoterol and Indacaterol from Marketed Dry Powder Inhalers
Dry powder inhalers (DPIs) are breath actuated devices relying on the inhalation effort generated by the patients during the inhalation manoeuvre to de-aggregate and disperse the powder formulationExpand
Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary disease.
TLDR
The ex vivo methodology used in this study provides a practical approach to identify the actual dose a patient might inhale during routine real-life use of the DuoResp Spiromax. Expand
In vitro evaluation of dry powder inhaler devices of corticosteroid preparations.
TLDR
In vitro differences in the aerosolization among different DPI devices containing ICS and combined drug preparations were observed, prescribers of these preparations should consider whether the patients will benefit more from the treatment of the central airways versus the peripheral airways. Expand
Total emitted dose of salbutamol sulphate at different inhalation flows and inhalation volumes through different types of dry powder inhalers
TLDR
Patients with poor inspiratory efforts to inhale twice and as hard and deep as possible from each dose as they may not receive much benefit from one inhalation even when using DPI with low resistance (Aerolizer) or medium resistance (Diskus); however, further in-vivo study are required to validate this recommendtation. Expand
Delivered Lung Dose and Aerodynamic Particle Size Distribution of Salbutamol Pressurized Metered Dose Inhaler After Living Under Patients' Realistic Retention Environments.
TLDR
Patients using V are expected to receive smaller lung doses during the hot summer season compared with intentionally well-kept VC, and V users should be advised to retain their inhalers around 20°C with minimal daily environmental fluctuations during summer times. Expand
Potential of a Cyclone Prototype Spacer to Improve In Vitro Dry Powder Delivery
TLDR
This work has shown the potential of employing a cyclone spacer for commercial carrier-based DPIs to improve inhaled drug delivery. Expand
The inhalation characteristics of patients when they use different dry powder inhalers.
TLDR
If inhalation profiles were used with compendial in vitro dose emission measurements, then the results would provide useful information about the dose patients inhale during routine use, and demonstrate the advantages of ΔP and ACCEL rather than PIFs. Expand
Aerodynamic dose emission characteristics of dry powder inhalers using an Andersen Cascade Impactor with a mixing inlet: the influence of flow and volume.
TLDR
The results highlight that the compendial methodology to use an inhaled volume of 4 L with the ACI could be replaced by 2 L and that the recommendation to make measurements using a pressure drop of 4kPa should be revised. Expand
The inhalation manager: a new computer-based device to assess inhalation technique and drug delivery to the patient.
  • W. Kamin, T. Genz, +4 authors T. Trammer
  • Medicine
  • Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine
  • 2003
TLDR
The development of a new system, the Inhalation Manager, which, for the first time, offers the possibility to assess the entire inhalation maneuver of patients using original devices under everyday conditions, and could become an essential tool in asthma management. Expand
Effect of dry powder inhaler resistance on the inspiratory flow rates and volumes of cystic fibrosis patients of six years and older.
  • H. Tiddens, D. Geller, +6 authors T. Standaert
  • Medicine
  • Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine
  • 2006
TLDR
The objective of this study was to assess the inspiratory variables of a representative population of CF subjects 6 years and older with varying degrees of lung disease while inhaling through resistances that simulate DPI devices, and to define ranges for inspiratory variable in a diverse CF population for a range of device resistance that bracket those of current DPIs. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 21 REFERENCES
Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma.
TLDR
The Diskus inhaler provides an improved dose consistency through the varying age groups and inspiratory flow performances when compared to the Turbuhaler in terms of the proportion of the dose emitted at each particle size. Expand
Influence of flow rate on aerosol particle size distributions from pressurized and breath-actuated inhalers.
  • K. J. Smith, H. Chan, K. Brown
  • Chemistry, Medicine
  • Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine
  • 1998
Particle size distribution of delivered aerosols and the total mass of drug delivered from the inhaler are important determinants of pulmonary deposition and response to inhalation therapy.Expand
Ex-vivo product performance of Diskus and Turbuhaler inhalers using inhalation profiles from patients with severe chronic obstructive pulmonary disease.
TLDR
The Diskus was shown to deliver a more consistent dose irrespective of flow than the Turbuhaler in this patient population, and may be of importance in optimising selection of devices for patients with severe airway obstruction. Expand
Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products.
  • D. L. Ross, R. Schultz
  • Chemistry, Medicine
  • Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine
  • 1996
TLDR
The Marple-Miller Cascade Impactor, a new multistage inertial impactor that operates at two flow rates (30 and 60 liters/min) with comparable particle size cut-offs, provides a means to study the effect of inhalation flow rate on the particle size distributions of inhalations products. Expand
Flow early in the inspiratory manoeuvre affects the aerosol particle size distribution from a Turbuhaler.
TLDR
Flow during the initial part of the inspiratory effort may be important in determining the characteristics of the aerosol generated by a dry powder inhaler, especially if the time to peak inspiratory flow is prolonged. Expand
The inhalation manager: a new computer-based device to assess inhalation technique and drug delivery to the patient.
  • W. Kamin, T. Genz, +4 authors T. Trammer
  • Medicine
  • Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine
  • 2003
TLDR
The development of a new system, the Inhalation Manager, which, for the first time, offers the possibility to assess the entire inhalation maneuver of patients using original devices under everyday conditions, and could become an essential tool in asthma management. Expand
A comparison of the performance of two modern multidose dry powder asthma inhalers.
TLDR
There were statistically significant differences in the drug emission of both dose and fine particle fraction of these two Powder inhalers delivering glucocorticosteroids. Expand
Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects.
TLDR
It is concluded that inspiratory flow has an important effect on lung deposition, but water solubility appears to have no effect. Expand
Lung deposition of budesonide in asthmatics: a comparison of different formulations
TLDR
The total lung deposition of budesonide via a pMDI and Turbuhaler in asthmatic patients in the present study was comparable with that previously found in healthy subjects. Expand
Variability in lung deposition of inhaled drug, within and between asthmatic patients, with a pMDI and a dry powder inhaler, Turbuhaler.
In vitro analysis of inhaled formulations measures, among other parameters, the variability in delivered dose, while a corresponding in vivo analysis also includes the variability caused by patientExpand
...
1
2
3
...